Accuray | ARAY - Current Assets


Accuray reported $303.6M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Accuray USD 303.6M 13.86M Sep/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 358.08M 20.58M Dec/2025
AtriCure USD 322.52M 21.41M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Inogen USD 203.72M 594K Sep/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 416.85M 22.68M Dec/2025
Surmodics USD 75.99M 5.31M Jun/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Trinity Biotech USD 35.52M 2.52M Sep/2025